What is the sequence and CAS number of TB-500?
PubChem records TB-500 as Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH (Ac-LKKTETQ), CID 62707662 and CAS 885340-08-9, with formula C38H68N10O14 and molar mass 889.0 g/mol. The sequence matches residues 17 to 23 of mature thymosin beta-4, with an acetyl group on the leucine that the natural protein does not carry at that position.
How does TB-500 differ from thymosin beta-4?
Thymosin beta-4 is a naturally occurring 43-residue peptide of about 4,963 g/mol. TB-500 is a seven-residue synthetic fragment of about 889 g/mol carrying only the central actin-binding sequence. Mass spectrometry separates them easily, and data on the full protein should not be attributed to the fragment.
What form is TB-500 supplied in?
TB-500 is supplied as a lyophilised (freeze-dried) powder in a sealed vial containing 10 mg, for laboratory and research use only. It is a research chemical, not a drug, food or cosmetic, and is not for human consumption.
What is the legal status of TB-500 in Australia?
TB-500 is listed in Schedule 4 of the June 2026 Poisons Standard and in Appendix D, clause 5, so it must not be possessed without authority; thymosin beta 4 is listed the same way. The TGA names TB-500 as an unapproved peptide product and says a research-use-only label does not make supply lawful.